The Ministry of Health of the Russian Federation’s recommendation for early detection of gastrointestinal diseases is published in the Journal of Gastroenterology, Hepatology, Coloproctology.
BIOHIT GROUP HALF YEAR FINANCIAL REPORT 2019
Biohit Oyj Half Year Financial Report 14 August 2019 at 9:30 am local time (EET)
Two clinical trials with Acetium® capsule for prevention of migraine-type headache have been concluded
In 2014, Biohit Oyj initiated two clinical trials for prevention of migraine-type headache attacks, testing the efficacy of Acetium® capsule. Because of a slow patient enrollment, the trial was subsequently extended to two additional clinical centers abroad. Read more
Safe diagnostics of Helicobacter pylori infection
STATE OF ART DIAGNOSIS OF HELICOBACTER PYLORI AND ITS CLINICAL SEQUELS – read the whole article.
May is the month for esophageal, intestinal and gastric health – How to prevent diseases and diagnose them early?
May is devoted to increase the awareness of digestive diseases and their prevention. Colorectal cancer is one of the most common types of cancer among the Finnish people. Biohit Oyj and UEG (United European Gastroenterology) encourage to prevention of these cancers by testing the intestinal and gastric health and by paying attention to a healthy lifestyle.
Constitutive meeting of Biohit Oyj’s Board of Directors
Biohit Oyj’s Board of Directors has in its meeting yesterday elected Mr Osmo Suovaniemi as the Chairman of the Board of Directors.
Decisions of the Annual General Meeting of Biohit Oyj
The Annual General Meeting (AGM) of Biohit Oyj held on Wednesday April 24, 2019 approved the financial statements of the parent company and the consolidated financial statements, and discharged the members of the Board of Directors and the President and CEO from liability for the financial year 2018.
Acetium® lozenge for smoking intervention will shortly be distributed in Italy within Difar Consumer Care® product division
Acetium® lozenge for smoking intervention will be available in Thailand during the year 2019
Biohit Oyj and Precision Health Co., Ltd have signed an agreement for the distribution of the Acetium lozenge in Thailand.
Biohit GastroPanel® biomarkers validated as powerful predictors of gastric cancer risk in a multicenter study
Biohit GastroPanel® innovation is the unique non-invasive diagnostic tool for examination of i) dyspeptic patients for exclusion or diagnosis of Helicobacter pylori (Hp) infection and atrophic gastritis (AG), also disclosing the functional status of gastric acid output, as well as ii) for screening of asymptomatic individuals for the risk of gastric cancer (GC) …